Please login to the form below

Not currently logged in

Katherine Baicker to join Lilly’s board of directors

Former US government health policy adviser to serve on US pharma company's public policy and compliance committee

Eli Lilly & Company has appointed former health policy adviser to the US government Dr Katherine Baicker to its board of directors.

She will serve on the public policy and compliance committee for the pharmaceutical company, whose CEO John Lechleiter hailed her as a leading researcher in the fields of health economics, public economics and labour economics.

“As a valued advisor to numerous healthcare-related commissions and committees, her expertise in healthcare policy and healthcare delivery is recognised by both academia and government. In a rapidly-changing healthcare landscape, Kate's insights will be invaluable as we work to sustain an environment that is conducive to medical innovation while still ensuring access to affordable, quality healthcare," he added.

Between 2005 and 2007, Baicker was a member of the President's Council of Economic Advisers, and currently serves as a research associate at the National Bureau of Economic Research and an elected member of the Institute of Medicine.

She also sits on the editorial boards of Health Affairs, the Journal of Health Economics, and the Forum for Health Economics and Policy.

13th December 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge